Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis?
Autor: | Reyna M. Durón, Edwin Francisco Herrera-Paz, Gaspar Rodríguez, Guímel Peralta, Céleo Ramírez |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
2019-20 coronavirus outbreak
medicine.medical_specialty lcsh:R5-920 Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) MEDLINE General Medicine Ivermectin Family medicine Commentary Medicine business lcsh:Medicine (General) Public health policy medicine.drug |
Zdroj: | EClinicalMedicine EClinicalMedicine, Vol 32, Iss, Pp 100744-(2021) |
ISSN: | 2589-5370 |
DOI: | 10.1016/j.eclinm.2021.100744 |
Databáze: | OpenAIRE |
Externí odkaz: |